Literature DB >> 17595505

Parvovirus B19 nonimmune hydrops in a neonate.

Ayush Manchanda1, Vikram Datta, Kush Jhunjhunwala, Arvind Saili, Ajay Kumar, Nidhi Agarwal.   

Abstract

Parvovirus B19 is responsible for approximately 10% of all cases of nonimmune hydrops. An unusual case of perinatally acquired parvovirus infection in a neonate is reported who presented with nonimmune hydrops fetalis at D15 of life.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17595505     DOI： 10.1007/s12098-007-0099-6

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   5.319


  12 in total

1.  Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians.

Authors:  J F Rodis; A F Borgida; M Wilson; J F Egan; M V Leo; A O Odibo; W A Campbell
Journal:  Am J Obstet Gynecol       Date:  1998-10       Impact factor: 8.661

2.  Human parvovirus B19 and hydrops fetalis.

Authors:  M J Anderson; M N Khousam; D J Maxwell; S J Gould; L C Happerfield; W J Smith
Journal:  Lancet       Date:  1988-03-05       Impact factor: 79.321

3.  Intrauterine infection with human parvovirus.

Authors: 
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

4.  Serologically proved intrauterine infection with parvovirus.

Authors:  P D Knott; G A Welply; M J Anderson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-15

5.  Detection of parvovirus B19 DNA in fetal tissues by in situ hybridisation and polymerase chain reaction.

Authors:  M M Salimans; F M van de Rijke; A K Raap; A M van Elsacker-Niele
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

6.  Elevated maternal serum alpha-fetoprotein and hydrops fetalis in association with fetal parvovirus B-19 infection.

Authors:  I M Bernstein; E L Capeless
Journal:  Obstet Gynecol       Date:  1989-09       Impact factor: 7.661

7.  The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome.

Authors:  E Gratacós; P J Torres; J Vidal; E Antolín; J Costa; M T Jiménez de Anta; V Cararach; P L Alonso; A Fortuny
Journal:  J Infect Dis       Date:  1995-05       Impact factor: 5.226

8.  Risk of adverse outcomes of pregnancy after human parvovirus B19 infection.

Authors:  J S Kinney; L J Anderson; J Farrar; R A Strikas; M L Kumar; R M Kliegman; J L Sever; E S Hurwitz; R K Sikes
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

9.  Detection of parvovirus B19 DNA, antigen, and particles in the human fetus.

Authors:  J P Clewley; B J Cohen; A M Field
Journal:  J Med Virol       Date:  1987-12       Impact factor: 2.327

10.  Maternal serum alpha-fetoprotein--a marker of fetal aplastic crisis during intrauterine human parvovirus infection.

Authors:  D Carrington; D H Gilmore; M J Whittle; D Aitken; A A Gibson; W J Patrick; T Brown; E O Caul; A M Field; J P Clewley
Journal:  Lancet       Date:  1987-02-21       Impact factor: 79.321
View more
  1 in total

1.  Detection of parvovirus B19 in selected high-risk patient groups & their phylogenetic & selection analysis.

Authors:  Kumaran Vadivel; Ramamurthy Mageshbabu; Sathish Sankar; Amita Jain; Vivekanandan Perumal; Padma Srikanth; Ghosh Asit Ranjan; Aravindan Nair; Eric A F Simoes; Balaji Nandagopal; Gopalan Sridharan
Journal:  Indian J Med Res       Date:  2018-04       Impact factor: 2.375
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.